Literature DB >> 17676349

[Topical treatment of persistent cutaneous leishmaniasis with paromomycin].

M J Flaig1, J Rupec, T Ruzicka, R A Rupec.   

Abstract

Cutaneous leishmaniasis is an infectious disease with increasing prevalence in Germany. Diagnosis and therapy may be difficult due to the variability of the clinical and histomorphological picture and resistance to therapy. In this case study we report on a female patient with a persistent cutaneous leishmaniasis successfully treated with topical administration of paromomycin.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17676349     DOI： 10.1007/s00105-007-1297-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  14 in total

Review 1.  Management of cutaneous leishmaniasis.

Authors:  N C Hepburn
Journal:  Curr Opin Infect Dis       Date:  2001-04       Impact factor: 4.915

2.  Treatment of cutaneous leishmaniasis with photodynamic therapy.

Authors:  Claes D Enk; Clemens Fritsch; Flory Jonas; Abedelmajeed Nasereddin; Arieh Ingber; Charles L Jaffe; Thomas Ruzicka
Journal:  Arch Dermatol       Date:  2003-04

Review 3.  Diagnosis of cutaneous leishmaniasis.

Authors:  Francisco Vega-López
Journal:  Curr Opin Infect Dis       Date:  2003-04       Impact factor: 4.915

4.  Comparison of PCR assays for diagnosis of cutaneous leishmaniasis.

Authors:  Esther Bensoussan; Abedelmajeed Nasereddin; Flory Jonas; Lionel F Schnur; Charles L Jaffe
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.

Authors:  A Stanimirović; T Stipić; M Skerlev; A Basta-Juzbasić
Journal:  J Eur Acad Dermatol Venereol       Date:  1999-11       Impact factor: 6.166

6.  Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.

Authors:  F Iraji; A Sadeghinia
Journal:  Ann Trop Med Parasitol       Date:  2005-01

7.  Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.

Authors:  A Asilian; T Jalayer; M Nilforooshzadeh; R L Ghassemi; R Peto; S Wayling; P Olliaro; F Modabber
Journal:  Bull World Health Organ       Date:  2003-07-07       Impact factor: 9.408

Review 8.  Treatment of cutaneous leishmaniasis among travellers.

Authors:  J Blum; P Desjeux; E Schwartz; B Beck; C Hatz
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

Review 9.  [Cutaneous leishmaniasis].

Authors:  C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

Review 10.  Leishmaniasis: current situation and new perspectives.

Authors:  P Desjeux
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268
View more
  1 in total

Review 1.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.